Business Context and Reporting Period
Company: Community Health Systems, Inc. (CHS)
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2025
Overview: CHS is a leading provider of healthcare services operating 69 affiliated hospitals with over 10,000 beds across 36 markets in 14 states. The company provides general acute care, emergency services, and outpatient care. As of December 31, 2025, the company employed approximately 57,000 people and 1,700 physicians.
Key Financial Metrics
| Metric (in millions) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net Operating Revenues | $12,485 | $12,634 | $12,490 |
| Net Income (Loss) Attributable to CHS | $509 | $(516) | $(133) |
| Adjusted EBITDA | $1,526 | $1,540 | $1,453 |
| Operating Cash Flow | $543 | $480 | $210 |
| Total Debt (Long-term + Current) | $10,396 | $11,452 | N/A |
| ABL Facility Capacity | $786 (Available) | N/A | N/A |
Note: Adjusted EBITDA is a non-GAAP measure. Net income for 2025 includes a $97 million pre-tax gain from early extinguishment of debt and a $406 million net gain on sale of businesses.
Material Changes vs. Prior Period
- Profitability Turnaround: The company returned to profitability in 2025 with $509 million in net income, reversing a $516 million loss in 2024. This was driven by a significant tax benefit ($163 million) from the 2025 Reconciliation Law, gains on divestitures, and improved operating margins.
- Revenue: Consolidated net operating revenues decreased 1.2% to $12.485 billion. However, on a same-store basis, revenues increased 4.6% due to higher reimbursement rates and favorable payor mix, offset by the divestiture of several hospitals.
- Divestitures: CHS completed the divestiture of four hospitals and the sale of a majority interest in three hospitals in 2025, generating over $1.0 billion in net proceeds. Additionally, the ambulatory outreach business was sold for $194 million.
- Debt Refinancing: The company issued $700 million of 10.75% Senior Secured Notes (2033) and $1.79 billion of 9.75% Senior Secured Notes (2034) to refinance maturing debt, resulting in a $97 million gain on early extinguishment.
- Volume: Consolidated inpatient admissions decreased 5.4% and adjusted admissions decreased 6.3% year-over-year, primarily due to divestitures. Same-store admissions increased 1.5% and 0.6%, respectively.
Guidance, Outlook, and Risks
Outlook and Legislative Impact: Management expects the 2025 Reconciliation Law to adversely impact revenue and financial results due to limitations on Medicaid eligibility and reductions in federal Medicaid funding. The law is expected to increase the self-pay patient population. Conversely, the law provided a significant one-time tax benefit in 2025. The company anticipates capital expenditures of $350 million to $400 million in 2026.
Key Risks and Contingencies:
- Regulatory Uncertainty: Significant uncertainty exists regarding the implementation of the 2025 Reconciliation Law, potential changes to Medicare/Medicaid reimbursement, and the expiration of ACA subsidies at the end of 2025.
- Indebtedness: The company carries substantial debt (~$10.4 billion). While it has $786 million in available borrowing capacity under its ABL facility, high interest rates and restrictive covenants pose liquidity risks.
- Legal Proceedings: CHS is subject to various legal and regulatory proceedings, including a DOJ investigation regarding a former employee's allegations and a criminal investigation into a former medical director. Management does not believe these will have a material adverse effect on financial position, but outcomes are uncertain.
- Cybersecurity: The company faces ongoing cyber threats. A security incident involving a third-party vendor occurred in 2023, and the risk of future breaches remains a material concern.
Investor Verification Checklist
- Divestiture Proceeds: Verify the final net proceeds from the 2025 hospital divestitures and the subsequent sales completed in early 2026 (e.g., Tennova Clarksville, Scranton hospitals) to confirm cash availability for debt reduction.
- Medicaid Exposure: Assess the specific impact of the 2025 Reconciliation Law on the company's revenue mix in the eight states where it operates that have expanded Medicaid, particularly regarding work requirements and federal matching fund reductions.
- Debt Service Coverage: Monitor the company's ability to service its high-interest debt load (average coupon rates on new notes are ~9.75% - 10.75%) given the projected reduction in government reimbursement rates.
- Professional Liability Reserves: Review the actuarial assumptions for professional liability claims, which totaled $638 million at year-end, to ensure reserves are adequate given "social inflationary pressures."
- Same-Store Performance: Track same-store revenue and admission growth to distinguish organic operational performance from the effects of portfolio restructuring.